|
|
|
WHO Level I and Level II Indicators Methodology to Assess Country Pharmaceutical Situations
|
To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system
of indicators to measure important aspects of country pharmaceutical situations. Level I indicators measure the
existence and performance of key national pharmaceutical structures and processes. Level II indicators measure
key outcomes of these structures and processes in the areas of access, product quality, and rational use.
These indicators can be used to assess progress over time; to compare situations across countries; and to
reassess and prioritize efforts based on the results.
Dennis Ross-Degnan, Anita Wagner, and Marsha Pierre-Jacques have been working with Daisy Carandang
at WHO Geneva on the development and refinement of the WHO strategy to systematically assess country pharmaceutical
situations using Level I and II indicators. Based on results from analyses of 1999 and 2003 indicator data
view here, the Level I key informant survey was revised
and is now being administered in all WHO member states.
Level II assessments now include a pricing survey view here
and a household survey view here. The Department
of Technical Cooperation on Essential Drugs and Traditional Medicines of WHO Geneva is supporting this work.
|
|
LATEST UPDATES
WHOCCPP
awarded funding for Interdisciplinary
Research and Training for Improving
Access to and Use of Medicines in China by Harvard
China Fund
Upcoming Courses
MedIC
Initiative Courses in Accra, Ghana, November 16-25, 2008
and Beijing, China in the Spring of 2009
|
